SCHEMBL8060090

SCHEMBL8060090

CC(C)(N)C#CC(O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445693 0.75
SCHEMBL30061413 0.72
SCHEMBL2442548 0.69 LMNA (0.39)
SCHEMBL10893086 0.67
SCHEMBL1358962 0.65
SCHEMBL8060088 0.65
SCHEMBL21307116 0.65
Ammonia Solution, Strong SCHEMBL9300246 0.63
Hydrochloric Acid SCHEMBL1359150 0.63
SCHEMBL10343112 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230115675-A1 METHODS OF TREATING CANCER BROAD INST INC (US) 2023-04-13 US disclosed
CN-115917324-A Methods of treating cancer 布罗德研究所有限公司 2023-04-04 CN disclosed
EP-4111202-A1 METHODS OF TREATING CANCER The Broad Institute Inc. (US) 2023-01-04 EP disclosed
US-11092602-B2 Methods and compositions relating to proteasome inhibitor resistance WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2021-08-17 US disclosed
US-20180353445-A1 METHODS AND COMPOSITIONS RELATING TO PROTEASOME INHIBITOR RESISTANCE WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 2018-12-13 US disclosed
US-20180306796-A1 METHODS AND COMPOSITIONS RELATING TO PROTEASOME INHIBITOR RESISTANCE HOWARD HUGHES MEDICAL INSTITUTE 2018-10-25 US disclosed
WO-2017007858-A1 METHODS AND COMPOSITIONS RELATING TO PROTEASOME INHIBITOR RESISTANCE WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-01-12 WO disclosed
EP-2958592-A1 METHODS OF TREATING CANCER AND PREVENTING DRUG RESISTANCE F. Hoffmann-La Roche AG (CH) 2015-12-30 EP disclosed
WO-2014128235-A1 METHODS OF TREATING CANCER AND PREVENTING DRUG RESISTANCE F. HOFFMANN-LA ROCHE AG (CH) 2014-08-28 WO disclosed
US-6028114-A Use of aminothiolester derivatives in pharmaceutics GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2000-02-22 US disclosed